Skip to content
Disclosery

University of Wisconsin Foundation

Follow

13F filer, CIK 1697228, MADISON, WI

University of Wisconsin Foundation reported $89,375,018 across 5 holdings for the quarter ended 2025-06-30, in a 13F-HR filed 2025-08-13.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001697228-25-000004

Period
2025-06-30
Reported value
$89.4M
Holdings
5
Top 10 weight
100%
New
0
Sold out
3

Largest buys vs the previous quarter

None.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
SEexited-307,504-$29M
IVVexited-12,555-$7.05M
SRPTexited-27,717-$1.77M
PDCCreduced-200-$3.6K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2025

Share positions as resolved from 13F-HR 0001697228-25-000004, largest first. % of portfolio is the value over $89,375,018, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
PDCCPEARL DIVER CREDIT COMPANY IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,459,221 shares; 2024Q4: 1,459,221 shares; 2025Q1: 1,459,221 shares; 2025Q2: 1,459,021 shares 1,459,021$26.2M29.35%-200Timeline
NUNU HLDGS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,431,951 shares; 2024Q4: 1,431,951 shares; 2025Q1: 1,431,951 shares; 2025Q2: 1,431,951 shares 1,431,951$19.6M21.98%0Timeline
AKROAKERO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 423,849 shares; 2024Q4: 410,630 shares; 2025Q1: 328,504 shares; 2025Q2: 328,504 shares 328,504$17.5M19.61%0Timeline
MDGLMADRIGAL PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 45,730 shares; 2024Q4: 41,541 shares; 2025Q1: 48,376 shares; 2025Q2: 48,376 shares 48,376$14.6M16.38%0Timeline
89BIO INC89BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 724,132 shares; 2024Q4: 917,357 shares; 2025Q1: 1,153,357 shares; 2025Q2: 1,153,357 shares 1,153,357$11.3M12.67%0

Sold out in Q2 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
SESEA LTD307,504$29Mshares
IVVISHARES TR12,555$7.05Mshares
SRPTSAREPTA THERAPEUTICS INC27,717$1.77Mshares

How Q2 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001697228-25-000004 base2025-08-13acceptance time not in the bulk data set